Keros Therapeutics Statistics
NASDAQ: KROSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.08-0.31 (-2.72%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Keros Therapeutics by the numbers
Keros Therapeutics has a market capitalization of $217.4 million based on 19.62M shares outstanding. With trailing EPS of $-2.32, Keros Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.4% above its 50-day average and 3.3% below its 200-day average.
Average daily trading volume is 196.50K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KROS valuation vs. peer median
| Metric | KROS | Peer median | Difference |
|---|---|---|---|
| Market cap | $217.44M | $215.61M | +1% |
| Avg. volume | 196.50K | 954.92K | -79% |
Peer median across 8 companies: RCKT, PYXS, IMRX, ARCT, ENTA, CYPH, VNDA, FTH.
Valuation
- Market cap
- $217.44M
- Price / sales (latest FY)
- 0.89
- EPS (TTM)
- $-2.32
- Shares outstanding
- 19.62M
Price and trading
- Previous close
- 11.39
- Open
- 11.13
- Day range
- 11.04 – 11.59
- 52-week range
- 8.98 – 22.55
- 52-week change
- -36.29%
- Beta
- —
- Volume
- 208.69K
- Average volume
- 196.50K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 217.44M
- Forward Pe
- -1.93
- Eps
- -2.32
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.55
- Week52 Low
- 8.98
- Avg Volume
- 196.50K
- Shares Outstanding
- 19.62M
- Ma50
- 11.03
- Ma200
- 11.45
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -50.86%
- Pct From52w Low
- 23.39%